Orchestra BioMed Holdings, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Orchestra BioMed Holdings, Inc. (OBIO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 22.32 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 22.41M shares, a 57.58% increase year-over-year.
- Orchestra BioMed Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 14.22M shares, a 12.56% increase year-over-year.
- Orchestra BioMed Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 12.63M shares, a 22.99% decline year-over-year.
- Orchestra BioMed Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 16.41M shares, a 1121.79% increase year-over-year.
- Orchestra BioMed Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 19.82M shares, a 38.67% increase from fiscal 2024.
- Orchestra BioMed Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 14.29M shares, a 13.54% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 12.59M shares, a 82.55% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.89M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 22.32M shares 10-Q · filed 2026-08-10 | ||||
| 2026-03-31 | 22.41M shares 10-Q · filed 2026-05-12 | ||||
| 2025-12-31 | 19.82M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 18.44M shares 10-Q · filed 2025-11-10 | ||||
| 2025-06-30 | 15.67M shares 10-Q · filed 2026-08-10 | ||||
| 2025-03-31 | 14.22M shares 10-Q · filed 2026-05-12 | ||||
| 2024-12-31 | 14.29M shares 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | 14.19M shares 10-Q · filed 2025-11-10 | ||||
| 2024-06-30 | 14.09M shares 10-Q · filed 2025-08-12 | ||||
| 2024-03-31 | 12.63M shares 10-Q · filed 2025-05-12 | ||||
| 2023-12-31 | 12.59M shares 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 13.17M shares 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | 10.75M shares 10-Q · filed 2024-08-12 | ||||
| 2023-03-31 | 16.41M shares 10-Q · filed 2024-05-13 | 3.94M shares 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | 6.89M shares 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | 3.07M shares 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 3.07M shares 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | 1.34M shares 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |